Delivery Order SPE2DX22D0099-SPE2D826FAB9E
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $116,799.91 to AmerisourceBergen Drug Corp on October 18, 2025, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The company, headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $87,605.42 to AmerisourceBergen Drug Corp on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,181.76 by the Defense Logistics Agency's Medical Supply Chain on June 28, 2025, with an ultimate completion date of June 30, 2025. This firm fixed-price delivery order is a non-set-aside contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which carries a $999,999,999.00 potential value through December 2026. The...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $133,270.80 by the Defense Logistics Agency Medical Supply Chain on September 30, 2025, with an ultimate completion date of October 1, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,251.32 by the Defense Logistics Agency's Medical Supply Chain on September 19, 2025. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by September 22, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $56,394.30 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,076.25 by the Defense Logistics Agency's Medical Supply Chain on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract and serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $71,848.92 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract, issued on September 1, 2025, with a completion date of September 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract valued at $140,578.74 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D826FAB9EDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $129,844.04 to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to military and federal healthcare systems worldwide. This delivery order exemplifies AmerisourceBergen's role as a critical vendor in the Defense Logistics Agency's medical procurement ecosystem. The company's federal contract portfolio demonstrates extensive capability in delivering a diverse range of pharmaceutical products, including specialty medications, generic and brand-name drugs, and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The Medical Supply Chain's reliance on AmerisourceBergen through both this delivery order and the larger prime IDC underscores the vendor's established ability to meet federal procurement standards through open competition and to fulfill complex, time-sensitive medical supply requirements for the Department of Defense and affiliated healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $129.8k | 11/7/25 |